BTX-1341

N/A

Report date: 2023/02/28 15:56:57
NME

Base Information

Drug NameBTX-1341
Drug Alias NameBTX1344BTX-1341BTX-1344BTX1341
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionProteolysis
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiotheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiotheryx Inc
Active IndicationsN/A
Inactive IndicationsHematologic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A